UK-based early stage investor Mercia Fund Management has named Peter Dines has investment director for its life sciences wing.
Dines, who brings with him two decades of healthcare sector experience which include founding and running life sciences businesses, will work alongside three other investment directors at the firm and will focus on medtech, contract services, and diagnostics as part of his life sciences remit.
Dines former companies include obstetrics equipment firm Surgicraft, which saw sales quadruple during his tenure and sold to Isis Equity Partners, as well as medtech Surgi C Group and distribution platform Newtech Ortho, both of which Dines founded and went on to hold successful acquisitions.
Mark Payton, managing director of Mercia Fund Management, said: “Peter brings significant experience and specialist expertise to the growing team at Mercia. He is highly regarded for his track record in identifying opportunities and growing value rapidly through hands-on management in businesses in the medtech and life sciences sector.”
